M5 Receptors

M5 receptors are members of the G-protein-coupled receptor (GPCR) family which are found mostly bound to Gq proteins. They are the last of five muscarinic receptors that act to control the metabotropic functions of acetylcholine (ACh) in the central nervous system (CNS).

Products
Background
Literature
Gene Data

Modulators

Cat No Product Name / Activity
3634 VU 0238429
Selective positive allosteric modulator of M5 receptors
4404 VU 0365114
Positive allosteric modulator of M5 receptors

M5 receptors are members of the G-protein-coupled receptor (GPCR) family which are found mostly bound to Gq proteins. They are the last of five muscarinic receptors that act to control the metabotropic functions of acetylcholine (ACh) in the central nervous system (CNS). M5 receptors are most densely populated in the dopamine-containing neuronal cells of the substantia nigra, hippocampus, cerebral cortex and striatum.

Activation of the M5 receptor leads to several responses, including the activation of ion channels such as K+ and Cl- and the inhibition of adenylyl cyclase. M5 receptor agonism modulates the activity of dopaminergic neurons and the release of dopamine into the striatum, which play an important role in mediating properties of abusive substances such as cocaine. In fact the M5 receptor has been implicated in drug addiction and may represent a therapeutic target. Endothelial M5 receptors also control the ability of acetylcholine to establish vasodilation in vascular beds, dramatically affecting cerebral blood flow.

M5 receptors may also be a potential therapeutic target in the treatment of memory deficits caused by impaired cerebrovascular function.

External sources of pharmacological information for M5 Receptors :

Literature for M5 Receptors

GPCR

GPCR Product Listing

A collection of over 450 products for G protein-coupled receptors, the listing includes research tools for the study of:

  • Rhodopsin-like Receptors
  • Secretin-like Receptors
  • Glutamate Receptors
  • Frizzled Receptors
  • GPCR Signaling
Alzheimer's

Alzheimer's Poster

Alzheimer's disease (AD) is a degenerative brain disease and the most common cause of dementia, affecting approximately 47 million people worldwide. Updated in 2015, this poster summarizes the structural and functional changes observed in the progression of this neurodegenerative disease, as well as classic AD drug targets.

Cardiovascular

Cardiovascular Poster

Cardiovascular disease remains one of the major causes of morbidity and mortality in the Western world and therefore this therapeutic area continues to be of great interest to researchers. This poster highlights the key GPCRs regulating vascular reactivity.

Learning & Memory

Learning & Memory Poster

Recognition memory enables us to make judgements about whether or not we have encountered a particular stimulus before. This poster outlines the cellular mechanisms underlying recognition memory and its links to long-term depression, as well as the use of pharmacological intervention to assess the role of neurotransmitters in recognition memory.

Schizophrenia

Schizophrenia Poster

Schizophrenia is a debilitating psychiatric disorder that affects 1% of the worldwide population. This poster describes the neurobiology of Schizophrenia, as well as highlighting the genetic and environmental factors that play a fundamental role in the etiology of the disease. The current and emerging drug targets are also discussed.

M5 Receptor Gene Data

Species Gene Symbol Gene Accession No. Protein Accession No.
Human CHRM5 NM_012125 P08912
Mouse Chrm5 NM_205783 Q920H4
Rat Chrm5 NM_017362 P08911